» Articles » PMID: 33987152

Early Postnatal Metabolic Profile in Neonates With Different Birth Weight Status: A Pilot Study

Abstract

Restricted or enhanced intrauterine growth is associated with elevated risks of early and late metabolic problems in humans. Metabolomics based on amino acid and carnitine/acylcarnitine profile may have a role in fetal and early postnatal energy metabolism. In this study, the relationship between intrauterine growth status and early metabolomics profile was evaluated. A single-center retrospective cohort study was conducted. Three hundred and sixty-one newborn infants were enrolled into the study, and they were grouped according to their birth weight percentile as small for gestational age (SGA, = 69), appropriate for gestational age (AGA, = 168), and large for gestational age (LGA, = 124) infants. In all infants, amino acid and carnitine/acylcarnitine profiles with liquid chromatography-tandem mass spectrometry (LC-MS/MS) were recorded and compared between groups. LGA infants had higher levels of glutamic acid and lower levels of ornithine, alanine, and glycine ( < 0.05) when compared with AGA infants. SGA infants had higher levels of alanine and glycine levels when compared with AGA and LGA infants. Total carnitine, C0, C2, C4, C5, C10:1, C18:1, C18:2, C14-OH, and C18:2-OH levels were significantly higher and C3 and C6-DC levels were lower in SGA infants ( < 0.05). LGA infants had higher C3 and C5:1 levels and lower C18:2 and C16:1-OH levels ( < 0.05). There were positive correlations between free carnitine and phenylalanine, arginine, methionine, alanine, and glycine levels ( < 0.05). Also, a positive correlation between ponderal index and C3, C5-DC, C14, and C14:1 and a negative correlation between ponderal index and ornithine, alanine, glycine, C16:1-OH, and C18:2 were shown. We demonstrated differences in metabolomics possibly reflecting the energy metabolism in newborn infants with intrauterine growth problems in the early postnatal period. These differences might be the footprints of metabolic disturbances in future adulthood.

Citing Articles

Metabolomic signatures associated with fetal growth restriction and small for gestational age: a systematic review.

Conde-Agudelo A, Villar J, Risso M, Papageorghiou A, Roberts L, Kennedy S Nat Commun. 2024; 15(1):9752.

PMID: 39528475 PMC: 11555221. DOI: 10.1038/s41467-024-53597-4.


Investigation of newborn blood metabolomics in varying intrauterine growth conditions.

Wang S, Lin X, Zhou Y, Yang X, Ou M, Zhang L J Pediatr (Rio J). 2024; 101(1):74-81.

PMID: 39178913 PMC: 11763542. DOI: 10.1016/j.jped.2024.07.009.


Metabolomics of a neonatal cohort from the Alliance for Maternal and Newborn Health Improvement biorepository: Effect of preanalytical variables on reference intervals.

Jafri L, Khan A, Ilyas M, Nisar I, Khalid J, Majid H PLoS One. 2023; 18(1):e0279931.

PMID: 36607993 PMC: 9821480. DOI: 10.1371/journal.pone.0279931.


Birth Weight and Early Postnatal Outcomes: Association with the Cord Blood Lipidome.

Gonzalez-Riano C, Santos M, Diaz M, Garcia-Beltran C, Lerin C, Barbas C Nutrients. 2022; 14(18).

PMID: 36145136 PMC: 9505183. DOI: 10.3390/nu14183760.


Metabolomics Applied to Cord Serum in Preeclampsia Newborns: Implications for Neonatal Outcomes.

Wang X, Liu J, Hui X, Song Y Front Pediatr. 2022; 10:869381.

PMID: 35547553 PMC: 9082809. DOI: 10.3389/fped.2022.869381.


References
1.
Mai M, Tonjes A, Kovacs P, Stumvoll M, Fiedler G, Leichtle A . Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS One. 2013; 8(12):e82459. PMC: 3865089. DOI: 10.1371/journal.pone.0082459. View

2.
Bene J, Hadzsiev K, Melegh B . Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutr Diabetes. 2018; 8(1):8. PMC: 5856836. DOI: 10.1038/s41387-018-0017-1. View

3.
Vidarsdottir H, Thorkelsson T, Halldorsson T, Bjarnason R, Geirsson R, Rinaldo P . Does metabolomic profile differ with regard to birth weight?. Pediatr Res. 2020; 89(5):1144-1151. DOI: 10.1038/s41390-020-1033-0. View

4.
Landmann E, Reiss I, Misselwitz B, Gortner L . Ponderal index for discrimination between symmetric and asymmetric growth restriction: percentiles for neonates from 30 weeks to 43 weeks of gestation. J Matern Fetal Neonatal Med. 2006; 19(3):157-60. DOI: 10.1080/14767050600624786. View

5.
Oey N, van Vlies N, Wijburg F, Wanders R, Attie-Bitach T, Vaz F . L-carnitine is synthesized in the human fetal-placental unit: potential roles in placental and fetal metabolism. Placenta. 2005; 27(8):841-6. DOI: 10.1016/j.placenta.2005.10.002. View